IL-33 in COVID-19: friend or foe?

Liang, Yuejin; Ge, Yiyue; Sun, Jiaren

Liang, Yuejin; Ge, Yiyue; Sun, Jiaren.

Liang Y; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA. yu2liang@utmb.edu.
Ge Y; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA. yu2liang@utmb.edu.
Sun J; NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.

Cell Mol Immunol ; 18(6): 1602-1604, 2021 06.

Article in English | MEDLINE | ID: covidwho-1223085

Subject(s)

COVID-19/immunology; Interleukin-33/immunology; SARS-CoV-2/immunology; Cell Line; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Interleukin-33 / SARS-CoV-2 / COVID-19 Limits: Humans Language: English Journal: Cell Mol Immunol Journal subject: Allergy and Immunology Year: 2021 Document Type: Article Affiliation country: S41423-021-00685-w

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google